149 related articles for article (PubMed ID: 34768211)
1. Improved prognostic stratification of patients with pN3b oral cavity cancer based on maximum standardized uptake value of metastatic nodes, lymph node ratio, and level of cervical nodal metastases.
Cheng NM; Kang CJ; Tsai CY; Lee LY; Lin CY; Hsueh C; Fan KH; Wang HM; Hsieh CH; Ng SH; Yeh CH; Lin CH; Tsao CK; Fang TJ; Huang SF; Lee LA; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Liao CT
Oral Oncol; 2021 Dec; 123():105593. PubMed ID: 34768211
[TBL] [Abstract][Full Text] [Related]
2. A combined analysis of maximum standardized uptake value on FDG-PET, genetic markers, and clinicopathological risk factors in the prognostic stratification of patients with resected oral cavity squamous cell carcinoma.
Liao CT; Hsieh CH; Fan WL; Ng SH; Cheng NM; Lee LY; Hsueh C; Lin CY; Fan KH; Wang HM; Lin CH; Tsao CK; Kang CJ; Fang TJ; Huang SF; Chang KP; Lee LA; Fang KH; Wang YC; Yang LY; Yen TC
Eur J Nucl Med Mol Imaging; 2020 Jan; 47(1):84-93. PubMed ID: 31388722
[TBL] [Abstract][Full Text] [Related]
3. Pathological risk factors stratification in pN3b oral cavity squamous cell carcinoma: Focus on the number of positive nodes and extranodal extension.
Liao CT; Lee LY; Hsueh C; Lin CY; Fan KH; Wang HM; Hsieh CH; Ng SH; Lin CH; Tsao CK; Kang CJ; Fang TJ; Huang SF; Chang KP; Yang LY; Yen TC
Oral Oncol; 2018 Nov; 86():188-194. PubMed ID: 30409299
[TBL] [Abstract][Full Text] [Related]
4. Lymph node ratio-dependent prognosis stratification and postoperative radiotherapy utilization in T1-2N1 oral cavity carcinoma.
Wang J; Liu Y; Shayan G; Ma Y; Yi J
Radiother Oncol; 2022 Jul; 172():83-90. PubMed ID: 35568286
[TBL] [Abstract][Full Text] [Related]
5. Assessing Prognostic Value of Quantitative Neck Dissection Quality Measures in Patients With Clinically Node-Negative Oral Cavity Squamous Cell Carcinoma.
Farrokhian N; Holcomb AJ; Dimon E; Karadaghy O; Ward C; Whiteford E; Tolan C; Hanly EK; Buchakjian MR; Harding B; Dooley L; Shinn J; Wood CB; Rohde S; Khaja S; Parikh A; Bulbul MG; Penn J; Goodwin S; Bur AM
JAMA Otolaryngol Head Neck Surg; 2022 Oct; 148(10):947-955. PubMed ID: 36074415
[TBL] [Abstract][Full Text] [Related]
6. Towards an Improved Pathological Node Classification for Prognostic Stratification of Patients With Oral Cavity Squamous Cell Carcinoma: Results From a Nationwide Registry Study.
Kang CJ; Wen YW; Lee SR; Ng SH; Tsai CY; Lee LY; Chu YH; Lin CY; Fan KH; Wang HM; Hsieh CH; Yeh CH; Lin CH; Tsao CK; Fang TJ; Huang SF; Lee LA; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Cheng NM; Liao CT
Front Oncol; 2022; 12():910158. PubMed ID: 35837108
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
[TBL] [Abstract][Full Text] [Related]
8. Influence of pathological nodal status and maximal standardized uptake value of the primary tumor and regional lymph nodes on treatment plans in patients with advanced oral cavity squamous cell carcinoma.
Liao CT; Wang HM; Chang JT; Lin CY; Ng SH; Huang SF; Chen IH; Hsueh C; Lee LY; Lin CH; Cheng AJ; Yen TC
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):421-9. PubMed ID: 20457351
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of lymph node involvement in oral squamous cell carcinoma.
Voss JO; Freund L; Neumann F; Mrosk F; Rubarth K; Kreutzer K; Doll C; Heiland M; Koerdt S
Clin Oral Investig; 2022 Nov; 26(11):6711-6720. PubMed ID: 35895143
[TBL] [Abstract][Full Text] [Related]
10. Preoperative [18F]fluorodeoxyglucose positron emission tomography standardized uptake value of neck lymph nodes predicts neck cancer control and survival rates in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes.
Liao CT; Chang JT; Wang HM; Ng SH; Hsueh C; Lee LY; Lin CH; Chen IH; Huang SF; Cheng AJ; Yen TC
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1054-61. PubMed ID: 19101096
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of patients with oral cavity squamous cell carcinoma and retropharyngeal lymph node metastasis identified by FDG PET/CT.
Tseng JR; Ho TY; Lin CY; Lee LY; Wang HM; Liao CT; Yen TC
PLoS One; 2013; 8(11):e79766. PubMed ID: 24244559
[TBL] [Abstract][Full Text] [Related]
12. Total lesion glycolysis: a possible new prognostic parameter in oral cavity squamous cell carcinoma.
Abd El-Hafez YG; Moustafa HM; Khalil HF; Liao CT; Yen TC
Oral Oncol; 2013 Mar; 49(3):261-8. PubMed ID: 23036774
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of lymph node ratio in patients with squamous cell carcinoma of the floor of the mouth.
Liu XC; Ma SR; Shi S; Zhao YF; Jia J
Int J Oral Maxillofac Surg; 2022 Mar; 51(3):307-313. PubMed ID: 34281747
[TBL] [Abstract][Full Text] [Related]
14. Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumor SUVmean has superior prognostic value.
Higgins KA; Hoang JK; Roach MC; Chino J; Yoo DS; Turkington TG; Brizel DM
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):548-53. PubMed ID: 21277108
[TBL] [Abstract][Full Text] [Related]
15. Association Between Lymph Node Ratio and Recurrence and Survival Outcomes in Patients With Oral Cavity Cancer.
Ding D; Stokes W; Eguchi M; Hararah M; Sumner W; Amini A; Goddard J; Somerset H; Bradley C; McDermott J; Raben D; Karam SD
JAMA Otolaryngol Head Neck Surg; 2019 Jan; 145(1):53-61. PubMed ID: 30452499
[TBL] [Abstract][Full Text] [Related]
16. Impact of lymph node ratio and number of lymph node metastases on survival and recurrence in laryngeal squamous cell carcinoma.
Molteni G; Nocini R; Mattioli F; Nakayama M; Dedivitis RA; Mannelli G; Crosetti E; Chiesa-Estomba CM; Sistiaga-Suarez JA; Giordano L; Galli A; Lionello M; Mercante G; Ralli M; Fermi M; Klein-Rodríguez A; Mayo-Yáñez M; Serafini E; Pirola F; Paderno A; Cambria F; Oridate N; Sano D; Boscolo-Rizzo P; Marcuzzo AV; Parrinello G; Marchi F; Saibene AM; Tucciarone M; Viscasillas G; Zeleník K; Ramos DM; Palacios-Garcia J; Tirelli G; Pellini R; Paludetti G; Galli J; Rossi G; De Vincentiis M; Cernea CR; Spriano G; Bussi M; Peretti G; Succo G; Piazza C; Bertolin A; Kowalski LP; Presutti L; Sacchetto A
Head Neck; 2023 Sep; 45(9):2274-2293. PubMed ID: 37496499
[TBL] [Abstract][Full Text] [Related]
17. Comparing prognostic utility between the 8th edition of TNM staging system and the lymph node ratio for oral squamous cell carcinoma.
Beltramini GA; Belloni LM; Fusco N; Sacconi A; Muti P; Baj A; Bolzoni AR; Giannì AB
Head Neck; 2021 Oct; 43(10):2876-2882. PubMed ID: 34115912
[TBL] [Abstract][Full Text] [Related]
18. Contribution of FDG-PET in the diagnostic assessment of cervical lymph node metastasis in Oral Cavity Squamous Cell Carcinoma (OCSCC).
Duvernay J; Schlund M; Majoufre C
J Stomatol Oral Maxillofac Surg; 2023 Dec; 124(6S):101659. PubMed ID: 37871651
[TBL] [Abstract][Full Text] [Related]
19. Nodal parameters of FDG PET/CT performed during radiotherapy for locally advanced mucosal primary head and neck squamous cell carcinoma can predict treatment outcomes: SUVmean and response rate are useful imaging biomarkers.
Lin P; Min M; Lee M; Holloway L; Forstner D; Bray V; Fowler A
Eur J Nucl Med Mol Imaging; 2017 May; 44(5):801-811. PubMed ID: 28004135
[TBL] [Abstract][Full Text] [Related]
20. Is Lymph Node Ratio a Prognostic Factor for Patients With Oral Squamous Cell Carcinoma?
Yamagata K; Fukuzawa S; Kanno N; Uchida F; Yanagawa T; Bukawa H
J Oral Maxillofac Surg; 2019 Jul; 77(7):1510-1519. PubMed ID: 30822404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
